The Patent Finder

Aprea AB

Also on record
Records under this name other than patents Aprea AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Aprea AB

PatentTitleStatus Expires Confidence
US 9,061,016Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,759,361Azabicyclooctan-3-one derivatives and use thereof
Formerly held
Term ended
Term ended Jun 2, 2025 · From the USPTO record
Term endedTerm ended Jun 2, 2025From the USPTO record
US 7,659,278Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
Formerly held
Term ended
Term ended May 18, 2024 · From the USPTO record
Term endedTerm ended May 18, 2024From the USPTO record
US 7,348,3301-azabicyclo [2,2,2] octan-3-one derivatives
Formerly held
Term ended
Term ended Mar 31, 2022 · From the USPTO record
Term endedTerm ended Mar 31, 2022From the USPTO record
US 6,921,7651-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
Formerly held
Term ended
Term ended Dec 30, 2021 · From the USPTO record
Term endedTerm ended Dec 30, 2021From the USPTO record
US 7,902,167Compounds and methods for down-regulating Wrap53 protein by RNA interference
Lapsed on the fee record
Ended Mar 8, 2015 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2015From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited